Scientific information remains useful only when its source, methods, population and limitations stay attached to the reported result.

A certificate is a batch-specific analytical record

A useful Certificate of Analysis identifies the tested batch, the reported result, the analytical procedure and the organization responsible for the record. It should allow the reader to connect a result to one physical lot rather than to a product name in general.

ICH Q2(R2) describes validation as the demonstration that an analytical procedure is fit for its intended purpose. The guideline addresses characteristics including specificity, accuracy, precision, range and robustness.

Evidence should become more specific as a claim becomes more consequential.

Read the method, not only the percentage

A purity percentage without method context is incomplete. Review whether identity and purity were assessed separately, whether the method is named, whether acceptance criteria are visible and whether the record is tied to the batch shown on the label.

Health Canada guidance describes reliable, complete, consistent and accurate records as a core part of data integrity. That principle is why EternaGen’s interface keeps the batch identifier, test result and source document together.

The EternaGen reporting standard
  • Link to the original source.
  • Name the study design and population.
  • Report the observed endpoint factually.
  • Disclose important limitations.
  • Never convert trial reporting into a product recommendation.

What the document does not establish

A COA does not by itself prove that every possible impurity was measured, that storage conditions were maintained after testing or that a material is suitable for a particular experiment. Those questions require additional method, chain-of-custody and handling information.

Displaying a certificate also does not establish regulatory approval or suitability for human or veterinary use.

Primary references

These sources were checked against the linked publisher, regulator or literature-index record on 20 July 2026.

  1. ICH Q2(R2). Validation of Analytical Procedures. Final version adopted 1 November 2023.
  2. Health Canada. Good manufacturing practices guide for drug products (GUI-0001), documentation and data-integrity principles.
Educational content only. This article does not constitute medical advice, a therapeutic claim or a recommendation for human or veterinary use.